Latin America Poultry Vaccines Market: By Vaccine Type, By Formulation Vaccines,Liquid Vaccines,Freeze Dried Vaccines), By Application,and Country Forecast 2021-2032
Report ID:20978
Published Date:Sep 2025
No of Pages:148
Format:
Latin America Poultry Vaccines Market size was valued at US$ 245.4 million in 2025 and is expected to reach US$ 440.1 million by 2032, growing at a significant CAGR of 8.7% from 2026-2032. Vaccines are biological preparations that provide acquired immunity to particular disease in human beings or animals. Poultry vaccines are used to prevent or cure the various diseases in poultry such as Mareks disease, Newcastle disease, and infectious diseases among others. Rise in population demand for healthy meat and poultry products, increase in adoption newer poultry vaccines, government initiations to protect the animal health and increase the poultry production, and increase in the number of poultry farms are expected boost the Latin America poultry vaccines market over the forecast period. However, stringent regulatory guidelines for vaccine approvals, lack of awareness about the poultry vaccination in underdeveloped countries, adverse effects associated with vaccines and high cost of vaccines may hamper the growth of Latin America poultry vaccines market in future years.
Study Period
2026-2032Base Year
2025CAGR
8.7%Largest Market
N/AFastest Growing Market
N/A
Government efforts, fast increase of the poultry population, rising prevalence of zoonotic illnesses, technical advancements, and rising demand for poultry-derived food items and poultry vaccination are the primary drivers driving the global poultry vaccines market forward.
Geographically, Latin America poultry vaccines market is segmented into Brazil, Mexico, Argentina, Venezuela, and Rest of Latin America. Brazil poultry vaccines market is growing due to rise in adoption of newer vaccines, grow in veterinary healthcare expenditure, and rise in prevalence of infectious diseases such as avian infectious bronchitis are bolster the market. Mexico poultry vaccines market exhibiting lucrative growth rate, which is attributed to expansion of business by the companies, and rise in awareness about the poultry diseases are fuel the maket. Argentina poultry vaccines market has a significant share owing to increase in the demand for healthy meat and poultry products, adoption of newer vaccines, and increase in per capita income.
Latin America
Europe
Asia Pacific
Middle East
North America
|
Report Benchmarks |
Details |
|
Report Study Period |
2026-2032 |
|
Market CAGR |
8.7% |
|
By Vaccine type |
|
|
By Formulation |
|
|
By Application |
|
Download Free Sample Report
Latin america poultry vaccines market size was valued at US$ X million in 2024 and is expected to reach US$ X million by 2031, growing at a significant CAGR of X%.
The market data: Latin America (Brazil, Mexico, Argentina)
The market key players are Zoetis (Pfizer, Inc.) (U.S.), Merck & Co. Inc. (U.S), Virbac S.A. (France), Boehringer Ingelheim Vetmedica (Germany), Elanco (U.S.), Bayer Animal Health (Germany), Phibro Animal health Corporation (U.S.), Zydus AHL (India), Ceva Sante Animale (France)
Content Updated Date: Jan 2026
| 1.Executive Summary |
| 2. Latin America Poultry Vaccines Market Introduction |
| 2.1. Latin America Poultry Vaccines Market - Taxonomy |
| 2.2. Latin America Poultry Vaccines Market - Definitions |
| 2.2.1.Vaccine type |
| 2.2.2.Formulation |
| 2.2.3.Application |
| 2.2.4.Country |
| 3. Latin America Poultry Vaccines Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4. Latin America Poultry Vaccines Market Analysis, 2020 - 2024 and Forecast 2025 - 2031 |
| 4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5. Latin America Poultry Vaccines Market By Vaccine type, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 5.1. Inactivated Vaccines |
| 5.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Live Attenuated Vaccines |
| 5.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. Recombinant Vaccines |
| 5.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 6. Latin America Poultry Vaccines Market By Formulation, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 6.1. Dry Form (Duct) Vaccines |
| 6.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Liquid Vaccines |
| 6.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Freeze Dried Vaccines |
| 6.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 7. Latin America Poultry Vaccines Market By Application, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 7.1. Mareks Disease |
| 7.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Newcastle Disease |
| 7.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Infectious Bursal Disease |
| 7.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 7.4. Infectious Bronchitis |
| 7.4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.4.3. Market Opportunity Analysis |
| 7.5. Others |
| 7.5.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.5.3. Market Opportunity Analysis |
| 8. Latin America Poultry Vaccines Market By Country, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 8.1. Brazil |
| 8.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. Mexico |
| 8.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 8.3. Argentina |
| 8.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.3.3. Market Opportunity Analysis |
| 8.4. Venezuela |
| 8.4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.4.3. Market Opportunity Analysis |
| 8.5. Rest of Latin America |
| 8.5.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.5.3. Market Opportunity Analysis |
| 9. Competition Landscape |
| 9.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 9.2.1.Zoetis (Pfizer, Inc.) (U.S.) |
| 9.2.2.Merck & Co. Inc. (U.S) |
| 9.2.3.Boehringer Ingelheim Vetmedica (Germany) |
| 9.2.4.Elanco (U.S.) |
| 9.2.5.Bayer Animal Health (Germany) |
| 9.2.6.Ceva Sante Animale (France) |
| 9.2.7.Zydus AHL (India) |
| 9.2.8.Hester Biosciences Limited. (India) |
| 9.2.9.Biovet (Brazil) |
| 10. Research Methodology |
| 11. Appendix and Abbreviations |
Key Market Players
Author
Manoj Kumar is a postgraduate in Life Sciences with over seven years of dedicated experience in the fields of animal health and agriculture. His passion lies in unraveling the complexities of these domains through rigorous research and practical insights. Manoj Kumar’s journey has been marked by several key achievements: as a market analyst and competitive intelligence expert, he dissects data to provide actionable insights for global clients. Simultaneously, he champions animal healthcare, diagnosing ailments, and designing preventive care strategies. In the realm of agriculture, his focus on sustainable practices, emphasizing crop nutrition, soil health, and precision agriculture. His holistic approach and commitment to advancing science make him a respected figure in the ever-evolving landscape of life sciences.
Download Sample
